$HLF

Jazz Pharmaceuticals (JAZZ) rose 2.5% after positive Phase 3 trial results. SAIC (SAIC) gained 5.5% on strong Q2 earnings. Herbalife (HLF) fell 13.2% following CEO's departure announcement. AGCO (AGCO) and Deere (DE) rose 4% and 3.1% respectively after Baird upgrades.

PG&E and Edison International fell 19% and 24% respectively after California blocked a wildfire liability proposal. Apple dropped 2% following a leadership change. SAIC rose 4% after raising its earnings forecast. Howmet Aerospace declined 8% due to SpaceX's in-house production plans. Herbalife fell 13% with CEO departure. Aon dropped 7% after a $17B acquisition. Energy stocks rose over 2% amid Middle East tensions. Eli Lilly fell 1% with a $2.9B acquisition. Pinterest dropped 6% with CFO depart

Nature's Sunshine (NYSE:USNA) reported $117M revenue, up 1.9% YoY, missing estimates. Herbalife (NYSE:HLF) reported $1.33B revenue, up 5.4%, beating estimates. Inter Parfums (NASDAQ:IPAR) reported $341M revenue, up 2.1%, beating estimates. All three stocks declined since earnings.

Herbalife (HLF) stock fell 12.7% after announcing CEO Stephan Gratziani will step down by October 31, 2026, with CFO John DeSimone as interim CEO. The company reaffirmed its Q3 and full-year 2026 financial guidance, projecting net sales growth of 0.5% to 4.5% and adjusted EBITDA of $160M to $180M. Broader market declines and geopolitical tensions also contributed to the sell-off.

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 31, 2026, the Company announced that Stephan Gratziani will transition from his role as Chief Executive Officer,

Herbalife (HLF) Q2 2026 earnings call highlights included CEO Stefan Graziani saying North America distributor productivity improved, including new distributors, and nutrition club productivity rose. CFO John De Simone said CapEx guidance range is narrowed modestly due to reprioritizing projects, with cash generation supporting investment. He cited manageable input cost pressure (whey, packaging, freight) and no change to leverage/debt reduction priorities.

Herbalife (NYSE:HLF) reported Q2 CY2026 revenue of $1.33 billion, up 5.4% year on year and about 1.5% above Wall Street estimates, according to the company. It guided next-quarter revenue near $1.31 billion. Non-GAAP EPS was $0.51, missing consensus by 4.9%. Shares fell 3.4% to $12.16 after results.

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONFIDENTIAL & PRIVILEGED Herbalife Reports Second Quarter Net Sales Growth; Marks Fourth Consecutive Quarter of Topline Expansion; Net Sales and Adjusted EBITDA 1 Exceed Guidance Excluding FX Headwinds 2 Advances Personalized Nutrition with Bioniq launch; CFO John D

Herbalife (NYSE: HLF) is set to report Q2 earnings Wednesday after market hours. Last quarter, it posted revenue of $1.32B, up 7.8% YoY, beating revenue estimates, with EPS beating but EBITDA missing. Q2 revenue is expected to rise 3.9% YoY. Analysts largely reconfirm estimates; average price target is $18.33 vs $12.73.

Stocks including Inter Parfums (IPAR), Estée Lauder (EL), and Herbalife (HLF) fell after President Trump said an Iran ceasefire was over and threatened further strikes. The article links the drop to higher crude oil costs and rising bond yields. For Estée Lauder, shares fell 3.6% to $81.54 and are down 23.6% YTD, trading 31.8% below its 52-week high.